Oliver N. Keene

机构：NSK (United Kingdom) · ORCID：0000-0003-0016-9773

发表论文 114 篇 · 总被引 15152 次 · h-index 37

代表论文

• Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma (2014 · New England Journal of Medicine · 被引 1677)
• Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies (2016 · The Lancet Respiratory Medicine · 被引 563)
• Biomarkers for severe eosinophilic asthma (2017 · Journal of Allergy and Clinical Immunology · 被引 229)
• Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis (2019 · American Journal of Respiratory and Critical Care Medicine · 被引 125)
• From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases (2021 · Allergy · 被引 116)
• Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma (2016 · Journal of Allergy and Clinical Immunology · 被引 94)